Skip to main content
Top
Published in: BMC Ophthalmology 1/2023

Open Access 01-12-2023 | Retinoblastoma | Research

Polyester 5–0 suture for porous implant placement after retinoblastoma enucleation: analysis of 120 sockets

Authors: Huijing Ye, Rongxin Chen, Wei Xiao, Xiufen Lian, Huasheng Yang

Published in: BMC Ophthalmology | Issue 1/2023

Login to get access

Abstract

Background

Techniques used to suture the rectus muscle to the implant can influence the implant-related complications which is still a major problem following retinoblastoma enucleation. The goals of this work were to report the efficacy among patients with retinoblastoma who underwent enucleation followed by porous implant placement with the rectus muscles sutured with 5–0 polyester suture.

Methods

This was a retrospective study of consecutive patients with retinoblastoma who underwent primary enucleation and porous implant placement with the rectus muscles tagged and sutured to the implant with polyester 5–0 suture. All the patients were followed up for a minimum of 2 years. The main outcome measure was implant exposure. The secondary efficacy measures were other implant-related complications.

Results

Between May 2016 and December 2018, a total of 120 patients (120 eyes) underwent primary enucleation and porous implant placement were included. Postoperatively, 10/120 (8.3%) eyes developed exposure or conjunctival granuloma. Exposure was the most common postoperative complication (7/10, 70.0%). There were no cases of implant extrusion, migration, or infection.

Conclusions

Polyester 5–0 sutures are successful in patients with retinoblastoma who underwent enucleation followed by porous implant placement. Complications are minimal. Polyester 5–0 sutures were not associated with unacceptable complications in this pediatric population.
Literature
1.
go back to reference Heimann H, Bechrakis NE, Zepeda LC, et al. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma. Ophthal Plast Reconstr Surg. 2005;21(2):123–8.CrossRef Heimann H, Bechrakis NE, Zepeda LC, et al. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma. Ophthal Plast Reconstr Surg. 2005;21(2):123–8.CrossRef
2.
go back to reference Lee V, Subak-Sharpe I, Hungerford JL, Davies NP, Logani S. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology. 2000;107(5):940–5 discussion 946.CrossRef Lee V, Subak-Sharpe I, Hungerford JL, Davies NP, Logani S. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology. 2000;107(5):940–5 discussion 946.CrossRef
3.
go back to reference Gunduz AK, Mirzayev I, Temel E, et al. A 20-year audit of retinoblastoma treatment outcomes. Eye (Lond). 2020;34(10):1916–24.CrossRef Gunduz AK, Mirzayev I, Temel E, et al. A 20-year audit of retinoblastoma treatment outcomes. Eye (Lond). 2020;34(10):1916–24.CrossRef
4.
go back to reference Shields CL, Fulco EM, Arias JD, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond). 2013;27(2):253–64.CrossRef Shields CL, Fulco EM, Arias JD, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond). 2013;27(2):253–64.CrossRef
5.
go back to reference Mirzayev I, Gunduz AK, Yavuz K, et al. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma. Eur J Ophthalmol. 2021;31(5):2692–8.CrossRef Mirzayev I, Gunduz AK, Yavuz K, et al. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma. Eur J Ophthalmol. 2021;31(5):2692–8.CrossRef
6.
go back to reference Francis JH, Roosipu N, Levin AM, et al. Current treatment of bilateral retinoblastoma: the impact of Intraarterial and Intravitreous chemotherapy. Neoplasia. 2018;20(8):757–63.CrossRef Francis JH, Roosipu N, Levin AM, et al. Current treatment of bilateral retinoblastoma: the impact of Intraarterial and Intravitreous chemotherapy. Neoplasia. 2018;20(8):757–63.CrossRef
7.
go back to reference Baino F, Perero S, Ferraris S, et al. Biomaterials for orbital implants and ocular prostheses: overview and future prospects. Acta Biomater. 2014;10(3):1064–87.CrossRef Baino F, Perero S, Ferraris S, et al. Biomaterials for orbital implants and ocular prostheses: overview and future prospects. Acta Biomater. 2014;10(3):1064–87.CrossRef
8.
go back to reference Mourits DL, Moll AC, Bosscha MI, Tan HS, Hartong DT. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature. Acta Ophthalmol. 2016;94(2):165–74.CrossRef Mourits DL, Moll AC, Bosscha MI, Tan HS, Hartong DT. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature. Acta Ophthalmol. 2016;94(2):165–74.CrossRef
9.
go back to reference Lang P, Kim JW, McGovern K, et al. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications. Orbit. 2018;37(6):438–43.CrossRef Lang P, Kim JW, McGovern K, et al. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications. Orbit. 2018;37(6):438–43.CrossRef
10.
go back to reference Iordanidou V, De Potter P. Porous polyethylene orbital implant in the pediatric population. Am J Ophthalmol. 2004;138(3):425–9.CrossRef Iordanidou V, De Potter P. Porous polyethylene orbital implant in the pediatric population. Am J Ophthalmol. 2004;138(3):425–9.CrossRef
11.
go back to reference Tabatabaee Z, Mazloumi M, Rajabi MT, Khalilzadeh O, et al. Comparison of the exposure rate of wrapped hydroxyapatite (bio-eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients. Ophthalmic Plast Reconstr Surg. 2011;27(2):114–8.CrossRef Tabatabaee Z, Mazloumi M, Rajabi MT, Khalilzadeh O, et al. Comparison of the exposure rate of wrapped hydroxyapatite (bio-eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients. Ophthalmic Plast Reconstr Surg. 2011;27(2):114–8.CrossRef
12.
go back to reference Al-Farsi HA, Sabt BI, Al-Mujaini AS. Orbital implant exposure following enucleation or evisceration. Oman J Ophthalmol. 2017;10(2):87–90. Al-Farsi HA, Sabt BI, Al-Mujaini AS. Orbital implant exposure following enucleation or evisceration. Oman J Ophthalmol. 2017;10(2):87–90.
13.
go back to reference Christmas NJ, Van Quill K, Murray TG, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol. 2000;118(4):503–6.CrossRef Christmas NJ, Van Quill K, Murray TG, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol. 2000;118(4):503–6.CrossRef
14.
go back to reference Kocaoglu B, Ulku TK, Gereli A, Karahan M, Turkmen M. Evaluation of absorbable and nonabsorbable sutures for repair of achilles tendon rupture with a suture-guiding device. Foot Ankle Int. 2015;36(6):691–5.CrossRef Kocaoglu B, Ulku TK, Gereli A, Karahan M, Turkmen M. Evaluation of absorbable and nonabsorbable sutures for repair of achilles tendon rupture with a suture-guiding device. Foot Ankle Int. 2015;36(6):691–5.CrossRef
15.
go back to reference Leknes KN, Selvig KA, Boe OE, Wikesjo UM. Tissue reactions to sutures in the presence and absence of anti-infective therapy. J Clin Periodontol. 2005;32(2):130–8.CrossRef Leknes KN, Selvig KA, Boe OE, Wikesjo UM. Tissue reactions to sutures in the presence and absence of anti-infective therapy. J Clin Periodontol. 2005;32(2):130–8.CrossRef
16.
go back to reference MacKoul P, Danilyants N, Sarfoh V, van der Does L, Kazi N. A retrospective review of vaginal cuff dehiscence: comparing absorbable and nonabsorbable sutures. J Minim Invasive Gynecol. 2020;27(1):122–8.CrossRef MacKoul P, Danilyants N, Sarfoh V, van der Does L, Kazi N. A retrospective review of vaginal cuff dehiscence: comparing absorbable and nonabsorbable sutures. J Minim Invasive Gynecol. 2020;27(1):122–8.CrossRef
17.
go back to reference Ye J, Gao Q, He JJ, et al. Exposure rate of unwrapped hydroxyapatite orbital implants in enucleation surgery. Br J Ophthalmol. 2016;100(6):860–5.CrossRef Ye J, Gao Q, He JJ, et al. Exposure rate of unwrapped hydroxyapatite orbital implants in enucleation surgery. Br J Ophthalmol. 2016;100(6):860–5.CrossRef
18.
go back to reference Andrianello S, Marchegiani G, Anselmi B, et al. Polyester preserves the highest breaking point after prolonged incubation in pancreatic juice. J Gastrointest Surg. 2018;22(3):444–50.CrossRef Andrianello S, Marchegiani G, Anselmi B, et al. Polyester preserves the highest breaking point after prolonged incubation in pancreatic juice. J Gastrointest Surg. 2018;22(3):444–50.CrossRef
19.
go back to reference Javed F, Al-Askar M, Almas K, Romanos GE, Al-Hezaimi K. Tissue reactions to various suture materials used in oral surgical interventions. ISRN Dent. 2012;2012:762095. Javed F, Al-Askar M, Almas K, Romanos GE, Al-Hezaimi K. Tissue reactions to various suture materials used in oral surgical interventions. ISRN Dent. 2012;2012:762095.
20.
go back to reference Verhoekx JSN, Rengifo Coolman A, Tse WHW, Paridaens D. A single- versus double-layered closure technique in Anophthalmic surgery. Ophthalmic Plast Reconstr Surg. 2017;33(5):329–33.CrossRef Verhoekx JSN, Rengifo Coolman A, Tse WHW, Paridaens D. A single- versus double-layered closure technique in Anophthalmic surgery. Ophthalmic Plast Reconstr Surg. 2017;33(5):329–33.CrossRef
21.
go back to reference Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthalmic Plast Reconstr Surg. 2004;20(4):274–80.CrossRef Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthalmic Plast Reconstr Surg. 2004;20(4):274–80.CrossRef
22.
go back to reference Bilyk JR. Enucleation, evisceration, and sympathetic ophthalmia. Curr Opin Ophthalmol. 2000;11(5):372–86.CrossRef Bilyk JR. Enucleation, evisceration, and sympathetic ophthalmia. Curr Opin Ophthalmol. 2000;11(5):372–86.CrossRef
23.
go back to reference Suter AJ, Molteno AC, Bevin TH, Fulton JD, Herbison P. Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86(11):1287–92.CrossRef Suter AJ, Molteno AC, Bevin TH, Fulton JD, Herbison P. Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86(11):1287–92.CrossRef
24.
go back to reference Mourits DL, Hartong DT, Bosscha MI, Kloos RJ, Moll AC. Worldwide enucleation techniques and materials for treatment of retinoblastoma: an international survey. PLoS One. 2015;10(3):e0121292.CrossRef Mourits DL, Hartong DT, Bosscha MI, Kloos RJ, Moll AC. Worldwide enucleation techniques and materials for treatment of retinoblastoma: an international survey. PLoS One. 2015;10(3):e0121292.CrossRef
25.
go back to reference Shome D, Honavar SG, Raizada K, Raizada D. Implant and prosthesis movement after enucleation: a randomized controlled trial. Ophthalmology. 2010;117(8):1638–44.CrossRef Shome D, Honavar SG, Raizada K, Raizada D. Implant and prosthesis movement after enucleation: a randomized controlled trial. Ophthalmology. 2010;117(8):1638–44.CrossRef
26.
go back to reference Taneja S, Aldoais T, Kaliki S. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases. Orbit. 2021;40(2):127–32.CrossRef Taneja S, Aldoais T, Kaliki S. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases. Orbit. 2021;40(2):127–32.CrossRef
27.
go back to reference Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthal Plast Reconstr Surg. 2007;23(1):1–7.CrossRef Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthal Plast Reconstr Surg. 2007;23(1):1–7.CrossRef
Metadata
Title
Polyester 5–0 suture for porous implant placement after retinoblastoma enucleation: analysis of 120 sockets
Authors
Huijing Ye
Rongxin Chen
Wei Xiao
Xiufen Lian
Huasheng Yang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2023
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-023-02787-7

Other articles of this Issue 1/2023

BMC Ophthalmology 1/2023 Go to the issue